Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder

BackgroundIt is known that patients reporting chronic pain often experience trauma or post-traumatic stress disorder (PTSD) and tend to be more difficult to treat. Attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, is frequently associated with chronic pain. Furthermore,...

Full description

Bibliographic Details
Main Authors: Satoshi Kasahara, Miwako Takahashi, Taito Morita, Ko Matsudaira, Naoko Sato, Toshimitsu Momose, Shin-Ichi Niwa, Kanji Uchida
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1221694/full
_version_ 1797752171766218752
author Satoshi Kasahara
Satoshi Kasahara
Miwako Takahashi
Taito Morita
Ko Matsudaira
Naoko Sato
Toshimitsu Momose
Shin-Ichi Niwa
Kanji Uchida
author_facet Satoshi Kasahara
Satoshi Kasahara
Miwako Takahashi
Taito Morita
Ko Matsudaira
Naoko Sato
Toshimitsu Momose
Shin-Ichi Niwa
Kanji Uchida
author_sort Satoshi Kasahara
collection DOAJ
description BackgroundIt is known that patients reporting chronic pain often experience trauma or post-traumatic stress disorder (PTSD) and tend to be more difficult to treat. Attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, is frequently associated with chronic pain. Furthermore, patients diagnosed with ADHD are more likely to encounter trauma and develop PTSD because of their inattentive and impulsive tendencies. There are reports stating that atomoxetine (ATX), a selective noradrenaline reuptake inhibitor for ADHD, is effective in patients diagnosed with PTSD and ADHD. However, there have been no reports on cases of comorbid PTSD and ADHD with chronic pain, and ATX’s potential in improving chronic pain coexisting PTSD. Furthermore, no reports have evaluated patient cerebral blood flow in conjunction with the course of treatment with ATX for chronic pain.Case reportIn this study, we reported a case where ATX improved chronic pain with PTSD and improved cerebral blood flow. The patient was a 56-year-old woman exhibiting chronic pain with PTSD, resulting from 6 years of severe domestic violence from her common-law husband. She had no history of ADHD diagnosis, but through aggressive screening, comorbid ADHD was diagnosed. When treated with ATX, there were significant improvements in her pain, quality of life, anxiety, depression, catastrophic thoughts, and cerebral blood flow. As a result, she could resume work after 11 years.ConclusionThe study showed that chronic pain with PTSD may be comorbid with ADHD. Moreover, we found that ATX can improve chronic pain with PTSD and cerebral blood flow. Aggressive screening of ADHD is important because once the diagnosis of comorbidity is confirmed, an ideal ADHD treatment can be selected. Therefore, based on the results of this study, ATX may be a candidate for treatment for cases of chronic pain with PTSD and ADHD.
first_indexed 2024-03-12T17:00:22Z
format Article
id doaj.art-fdd9ee97cff44b719c1404c989e4c276
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-03-12T17:00:22Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-fdd9ee97cff44b719c1404c989e4c2762023-08-07T18:13:50ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-08-011410.3389/fpsyt.2023.12216941221694Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorderSatoshi Kasahara0Satoshi Kasahara1Miwako Takahashi2Taito Morita3Ko Matsudaira4Naoko Sato5Toshimitsu Momose6Shin-Ichi Niwa7Kanji Uchida8Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, JapanDepartment of Pain Medicine, Fukushima Medical University School of Medicine, Fukushima, JapanInstitute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, JapanDepartment of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, JapanDepartment of Pain Medicine, Fukushima Medical University School of Medicine, Fukushima, JapanNursing Department, The University of Tokyo Hospital, Tokyo, JapanInstitute of Engineering Innovation, School of Engineering, The University of Tokyo, Tokyo, JapanDepartment of Psychiatry, Aizu Medical Center, Fukushima Medical University, Fukushima, JapanDepartment of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, JapanBackgroundIt is known that patients reporting chronic pain often experience trauma or post-traumatic stress disorder (PTSD) and tend to be more difficult to treat. Attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, is frequently associated with chronic pain. Furthermore, patients diagnosed with ADHD are more likely to encounter trauma and develop PTSD because of their inattentive and impulsive tendencies. There are reports stating that atomoxetine (ATX), a selective noradrenaline reuptake inhibitor for ADHD, is effective in patients diagnosed with PTSD and ADHD. However, there have been no reports on cases of comorbid PTSD and ADHD with chronic pain, and ATX’s potential in improving chronic pain coexisting PTSD. Furthermore, no reports have evaluated patient cerebral blood flow in conjunction with the course of treatment with ATX for chronic pain.Case reportIn this study, we reported a case where ATX improved chronic pain with PTSD and improved cerebral blood flow. The patient was a 56-year-old woman exhibiting chronic pain with PTSD, resulting from 6 years of severe domestic violence from her common-law husband. She had no history of ADHD diagnosis, but through aggressive screening, comorbid ADHD was diagnosed. When treated with ATX, there were significant improvements in her pain, quality of life, anxiety, depression, catastrophic thoughts, and cerebral blood flow. As a result, she could resume work after 11 years.ConclusionThe study showed that chronic pain with PTSD may be comorbid with ADHD. Moreover, we found that ATX can improve chronic pain with PTSD and cerebral blood flow. Aggressive screening of ADHD is important because once the diagnosis of comorbidity is confirmed, an ideal ADHD treatment can be selected. Therefore, based on the results of this study, ATX may be a candidate for treatment for cases of chronic pain with PTSD and ADHD.https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1221694/fullatomoxetineattention deficit hyperactivity disordercerebral blood flowchronic painpost-traumatic stress disordersingle-photon emission computed tomography
spellingShingle Satoshi Kasahara
Satoshi Kasahara
Miwako Takahashi
Taito Morita
Ko Matsudaira
Naoko Sato
Toshimitsu Momose
Shin-Ichi Niwa
Kanji Uchida
Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
Frontiers in Psychiatry
atomoxetine
attention deficit hyperactivity disorder
cerebral blood flow
chronic pain
post-traumatic stress disorder
single-photon emission computed tomography
title Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
title_full Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
title_fullStr Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
title_full_unstemmed Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
title_short Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
title_sort case report atomoxetine improves chronic pain with comorbid post traumatic stress disorder and attention deficit hyperactivity disorder
topic atomoxetine
attention deficit hyperactivity disorder
cerebral blood flow
chronic pain
post-traumatic stress disorder
single-photon emission computed tomography
url https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1221694/full
work_keys_str_mv AT satoshikasahara casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT satoshikasahara casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT miwakotakahashi casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT taitomorita casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT komatsudaira casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT naokosato casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT toshimitsumomose casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT shinichiniwa casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder
AT kanjiuchida casereportatomoxetineimproveschronicpainwithcomorbidposttraumaticstressdisorderandattentiondeficithyperactivitydisorder